[go: up one dir, main page]

DK1170003T3 - Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler - Google Patents

Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler

Info

Publication number
DK1170003T3
DK1170003T3 DK00115408T DK00115408T DK1170003T3 DK 1170003 T3 DK1170003 T3 DK 1170003T3 DK 00115408 T DK00115408 T DK 00115408T DK 00115408 T DK00115408 T DK 00115408T DK 1170003 T3 DK1170003 T3 DK 1170003T3
Authority
DK
Denmark
Prior art keywords
fat
soluble drugs
self
delivery system
drug delivery
Prior art date
Application number
DK00115408T
Other languages
English (en)
Inventor
Sue San David Ho
Kah Hay Assoc Prof Dr Yuen
Siew Ping Yap
Original Assignee
Hovid Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovid Sdn Bhd filed Critical Hovid Sdn Bhd
Application granted granted Critical
Publication of DK1170003T3 publication Critical patent/DK1170003T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK00115408T 2000-07-07 2000-07-17 Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler DK1170003T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/612,434 US6596306B1 (en) 2000-07-07 2000-07-07 Drug delivery system:formulation for fat-soluble drugs

Publications (1)

Publication Number Publication Date
DK1170003T3 true DK1170003T3 (da) 2006-08-07

Family

ID=24453141

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00115408T DK1170003T3 (da) 2000-07-07 2000-07-17 Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler

Country Status (9)

Country Link
US (1) US6596306B1 (da)
EP (1) EP1170003B1 (da)
AT (1) ATE322250T1 (da)
CY (1) CY1105026T1 (da)
DE (1) DE60027142T2 (da)
DK (1) DK1170003T3 (da)
ES (1) ES2255924T3 (da)
PT (1) PT1170003E (da)
TW (1) TWI222880B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100361656C (zh) 2004-08-27 2008-01-16 石药集团中奇制药技术(石家庄)有限公司 丁苯酞自乳化释药体系及其制备方法和应用
MY139644A (en) * 2005-02-17 2009-10-30 Palm Nutraceuticals Sdn Bhd Improving the quality of crude oils and fats and recovery of minor components
KR20160029866A (ko) * 2007-05-25 2016-03-15 더 유니버시티 오브 브리티쉬 콜롬비아 치료제의 경구 투여를 위한 제제 및 관련 방법
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
WO2013059729A1 (en) * 2011-10-21 2013-04-25 First Tech International Limited Tocotrienol compositions
SG11201405357SA (en) 2012-03-01 2014-10-30 Array Biopharma Inc Crystalline forms of 1- (3 -tert-butyl- 1 - p-tolyl- 1h- pyrazol- 5 -yl) -3- (5-fluoro-2- (1- ( 2 - hydroxyethyl) - indazol- 5 -yloxy) benzyl) urea hydrochloride
EP2861069A4 (en) * 2012-05-18 2016-03-30 Univ Ohio State METHOD FOR IMPROVING THE LIVER FUNCTION
KR20150024888A (ko) 2012-06-08 2015-03-09 더 오하이오 스테이트 유니버시티 토코트리에놀을 사용한 화상 및 흉터 상해 치료
US20150139938A1 (en) * 2012-06-08 2015-05-21 Ohio State Innovation Foundation Methods and Compositions for Improving Pial Collateral Circulation and Treating Blood Clotting Disorders
JP6723166B2 (ja) * 2014-06-19 2020-07-15 ソルラル ファーマ エーピーエス 親油性の化合物の固体経口剤形
MY182652A (en) * 2014-11-25 2021-01-27 Kl Kepong Oleomas Sdn Bhd Formulation for effective tocotrienol delivery
US10137164B2 (en) 2015-01-02 2018-11-27 Melaleuca, Inc. Dietary supplement compositions
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物
TWI759260B (zh) 2015-01-02 2022-04-01 美商梅拉洛伊卡公司 多元補充品組成物
WO2022150435A1 (en) * 2021-01-06 2022-07-14 The Trustees Of Indiana University Tocotrienol compositions and methods to treat non-alcoholic steatohepatitis
MY203355A (en) 2021-12-27 2024-06-25 Sd Guthrie Intellectual Property Sdn Bhd Self-emulsifying composition
WO2025153898A1 (en) * 2024-01-19 2025-07-24 Gene Company Pty Ltd Retinoid compositions and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141051A3 (de) * 1983-08-16 1986-10-01 Roshdy Dr. Ismail Weichgelatinekapseln enthaltend Vitamin A und E
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
CA2185803C (en) * 1994-03-18 2006-07-11 Edward M. Rudnic Emulsified drug delivery systems
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5479540A (en) * 1994-06-30 1995-12-26 The Whitaker Corporation Passively aligned bi-directional optoelectronic transceiver module assembly
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5883103A (en) * 1995-06-07 1999-03-16 Shire Laboratories Inc. Oral acyclovir delivery
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
GB9817650D0 (en) * 1998-08-14 1998-10-07 Danbiosyst Uk Oral formulation
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same

Also Published As

Publication number Publication date
CY1105026T1 (el) 2009-11-04
PT1170003E (pt) 2006-06-30
DE60027142D1 (de) 2006-05-18
ES2255924T3 (es) 2006-07-16
ATE322250T1 (de) 2006-04-15
TWI222880B (en) 2004-11-01
EP1170003A1 (en) 2002-01-09
US6596306B1 (en) 2003-07-22
DE60027142T2 (de) 2006-12-14
EP1170003B1 (en) 2006-04-05

Similar Documents

Publication Publication Date Title
DK1170003T3 (da) Selvemulgerende lægemiddelleveringssystem til fedtoplöselige lægemidler
DE60131862D1 (de) Herstellung von vitaminemulsionen und konzentrate davon
ATE415942T1 (de) Prostaglandine enthaltende ophthalmische emulsionen
ATE503460T1 (de) Selbstmikroemulgierende arzneiabgabesysteme
WO2007106284A3 (en) Silicone based emulsions for topical drug delivery
ES2104522T3 (es) Nuevo sistema de administracion de medicamento.
DE50108380D1 (de) Hautbehandlungsmittel
HRP20080235T3 (hr) Formulacija vakcine koja sadrži emulziju ulje-u-vodi
NO20002991D0 (no) Farmasøytiske sammensetninger som inneholder en omega-3- fettsyreolje
SE0003449L (sv) Cancerhämmande kompositioner
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
DE50106562D1 (de) Kosmetische und pharmazeutische Öl-in-Wasser-Emulsionen von polyethermodifizierten Polysiloxanen
AU3030801A (en) Fenofibrate galenic formulations and method for obtaining same
NO20024272L (no) Nytt selvemulgerende legemiddelavleveringssystem
NO20025629D0 (no) Formulering
DK1267831T3 (da) Hidtil ukendt selvemulgerende system til lægemiddelindgift
EA200301019A1 (ru) Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин
Subudhi et al. Self‐Microemulsifying Drug Delivery System: Formulation and Study Intestinal Permeability of Ibuprofen in Rats
WO2006021160A8 (fr) Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
DK1250125T3 (da) Farmaceutiske præparater, som indeholder terbinafin
TH100976A (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
TH100976B (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
Buyukozturk et al. Self emulsifying drug delivery system release kinetics: Dependence on physical and chemical emulsion formulation properties
안용산 et al. Preparation and characterization of dexibuprofen using self micro emulsifying drug delivery systems (SMEDDS) in vivo